SOTORASIB

SOTORASIB was reported 3470 times

SOTORASIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ALLOIMMUNE HEPATITIS 1 0.1429
1 HEPATIC HAEMANGIOMA RUPTURE 1 0.1250
2 NON-SMALL CELL LUNG CANCER METASTATIC 98 0.1115
3 NON-SMALL CELL LUNG CANCER 520 0.1084
4 SARCOMATOID CARCINOMA OF THE LUNG 2 0.0952
5 PYLORIC ABSCESS 1 0.0909
6 LARGE CELL LUNG CANCER 2 0.0870
7 RETROPERITONEAL DISORDER 1 0.0435
8 LUNG ADENOCARCINOMA RECURRENT 4 0.0388
9 NEUROENDOCRINE TUMOUR OF THE LUNG METASTATIC 2 0.0370
10 OESOPHAGEAL MUCOSAL BLISTER 1 0.0345
11 BRACHYTHERAPY 1 0.0312
12 PERICARDITIS MALIGNANT 3 0.0280
13 EXTRAMEDULLARY HAEMOPOIESIS 4 0.0250
14 ADRENAL GLAND INJURY 1 0.0227
15 NON-SMALL CELL LUNG CANCER RECURRENT 6 0.0212
16 LUNG ADENOCARCINOMA STAGE IV 8 0.0209
17 METASTATIC BRONCHIAL CARCINOMA 4 0.0208
18 RECTAL CANCER METASTATIC 7 0.0201
19 NON-SMALL CELL LUNG CANCER STAGE IV 7 0.0192
20 INGUINAL HERNIA STRANGULATED 1 0.0182
21 INTESTINAL TRANSIT TIME ABNORMAL 1 0.0182
22 LUNG ADENOCARCINOMA 52 0.0173
23 OPHTHALMIC ARTERY OCCLUSION 1 0.0172
24 RADIOTHERAPY TO BRAIN 1 0.0161
25 COLORECTAL CANCER METASTATIC 36 0.0152
26 MENINGEAL NEOPLASM 1 0.0149
27 BRAIN RADIATION NECROSIS 1 0.0135
28 BREAST PROSTHESIS REMOVAL 1 0.0123
29 IMMUNE-MEDIATED HYPERTHYROIDISM 3 0.0118
30 LUNG ADENOCARCINOMA STAGE III 1 0.0115
31 SOMATIC HALLUCINATION 1 0.0111
32 BRONCHOSCOPY ABNORMAL 1 0.0104
33 ADENOCARCINOMA METASTATIC 2 0.0097
34 MUCOCUTANEOUS TOXICITY 1 0.0095
35 CRYSTAL ARTHROPATHY 2 0.0095
36 K-RAS GENE MUTATION 1 0.0094
37 BILIRUBIN CONJUGATED ABNORMAL 1 0.0090
38 KL-6 INCREASED 2 0.0088
39 LUNG CANCER METASTATIC 25 0.0087
40 MALIGNANT URINARY TRACT NEOPLASM 1 0.0084
41 CANCER FATIGUE 2 0.0084
42 PANCREATIC TOXICITY 1 0.0083
43 BRACHIOCEPHALIC VEIN THROMBOSIS 1 0.0081
44 TUMOUR HYPERPROGRESSION 2 0.0081
45 COLORECTAL CANCER RECURRENT 1 0.0078
46 INFESTATION 2 0.0077
47 JAW FISTULA 1 0.0077
48 HYPERADRENOCORTICISM 2 0.0073
49 HYPERCAPNIC COMA 1 0.0070
50 MUCOCUTANEOUS DISORDER 1 0.0063
51 RADIOTHERAPY 12 0.0063
52 CERVIX CANCER METASTATIC 1 0.0061
53 HANGNAIL 1 0.0058
54 BILIARY CYST 1 0.0057
55 CARCINOEMBRYONIC ANTIGEN INCREASED 11 0.0057
56 DRUG RESISTANCE MUTATION 1 0.0056
57 PERICARDIAL EFFUSION MALIGNANT 1 0.0056
58 INTESTINAL ADENOCARCINOMA 1 0.0053
59 RADIATION NECROSIS 3 0.0052
60 COOMBS NEGATIVE HAEMOLYTIC ANAEMIA 1 0.0051
61 HERPES SIMPLEX TEST POSITIVE 1 0.0050
62 METASTASES TO ABDOMINAL WALL 1 0.0050
63 MALIGNANT NEOPLASM OLIGOPROGRESSION 1 0.0050
64 GASTROSTOMY TUBE SITE COMPLICATION 1 0.0050
65 TUMOUR ASSOCIATED FEVER 2 0.0049
66 LUNG CARCINOMA CELL TYPE UNSPECIFIED RECURRENT 3 0.0048
67 HEPATOBILIARY DISEASE 3 0.0048
68 BACTERIAL DIARRHOEA 1 0.0047
69 HEPATOTOXICITY 103 0.0046
70 RECTOSIGMOID CANCER 1 0.0045
71 DEGENERATIVE BONE DISEASE 2 0.0045
72 THERAPY PARTIAL RESPONDER 68 0.0044
73 SQUAMOUS CELL CARCINOMA OF HEAD AND NECK 1 0.0043
74 PRURITUS ALLERGIC 5 0.0043
75 PANCREATIC CARCINOMA RECURRENT 1 0.0041
76 ALBUMINURIA 2 0.0037
77 HYPERCALCAEMIA OF MALIGNANCY 1 0.0037
78 MORAXELLA INFECTION 1 0.0036
79 DUODENOGASTRIC REFLUX 1 0.0036
80 HYPERTRANSAMINASAEMIA 25 0.0036
81 METASTASES TO NECK 1 0.0036
82 PRODUCT INFORMATION CONTENT COMPLAINT 1 0.0036
83 ANTICOAGULANT THERAPY 1 0.0035
84 HEPATIC CANCER RECURRENT 1 0.0035
85 ACUTE POLYNEUROPATHY 1 0.0035
86 BLOOD CORTICOTROPHIN INCREASED 1 0.0035
87 TRANSAMINASES ABNORMAL 2 0.0034
88 NAIL TOXICITY 1 0.0033
89 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 4 0.0033
90 BLOOD ALKALINE PHOSPHATASE ABNORMAL 3 0.0033
91 GASTROINTESTINAL TOXICITY 16 0.0033
92 SUPERIOR VENA CAVA SYNDROME 2 0.0033
93 RECTAL ADENOCARCINOMA 2 0.0033
94 ERYTHROPENIA 1 0.0033
95 MYOCARDIAL RUPTURE 1 0.0033
96 METASTASES TO OVARY 1 0.0031
97 BLOOD BILIRUBIN ABNORMAL 4 0.0031
98 ADENOCARCINOMA 7 0.0031
99 ANALGESIC THERAPY 1 0.0031
100 METASTASES TO MENINGES 7 0.0031
101 POST PROCEDURAL CONTUSION 1 0.0030
102 TUMOUR PAIN 4 0.0030
103 DISEASE PROGRESSION 348 0.0029
104 IMMUNE-MEDIATED HEPATITIS 6 0.0029
105 CAROTID ARTERY ANEURYSM 1 0.0029
106 HEPATIC CYTOLYSIS 37 0.0029
107 NEUROENDOCRINE CARCINOMA 2 0.0029
108 LOWER URINARY TRACT SYMPTOMS 1 0.0028
109 INTESTINAL METASTASIS 1 0.0028
110 CEREBRAL MASS EFFECT 1 0.0028
111 METASTASES TO CENTRAL NERVOUS SYSTEM 35 0.0027
112 HEPATIC FUNCTION ABNORMAL 101 0.0027
113 MEDIASTINAL DISORDER 1 0.0027
114 MICROALBUMINURIA 2 0.0026
115 SQUAMOUS CELL CARCINOMA OF LUNG 2 0.0026
116 MALIGNANT ASCITES 2 0.0026
117 ADMINISTRATION SITE REACTION 1 0.0026
118 CHRONIC HEPATITIS C 1 0.0025
119 MENINGEAL DISORDER 1 0.0025
120 REPRODUCTIVE TRACT DISORDER 1 0.0025
121 ACNE PUSTULAR 2 0.0024
122 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 2 0.0024
123 MALIGNANT PLEURAL EFFUSION 4 0.0024
124 BILIARY OBSTRUCTION 3 0.0023
125 THALAMUS HAEMORRHAGE 2 0.0023
126 REFLUX LARYNGITIS 1 0.0023
127 MALIGNANT TRANSFORMATION 1 0.0022
128 HYPERPLASIA 2 0.0022
129 CEREBRAL MICROHAEMORRHAGE 1 0.0022
130 HERPES SIMPLEX ENCEPHALITIS 1 0.0022
131 LIVER FUNCTION TEST INCREASED 46 0.0021
132 LUNG NEOPLASM MALIGNANT 85 0.0021
133 DUODENAL STENOSIS 1 0.0021
134 SALIVARY GLAND CANCER 1 0.0020
135 GENE MUTATION 4 0.0020
136 ONYCHALGIA 2 0.0020
137 HYPERCREATININAEMIA 1 0.0020
138 DERMATITIS ACNEIFORM 12 0.0020
139 ASPARTATE AMINOTRANSFERASE ABNORMAL 3 0.0020
140 AORTIC VALVE CALCIFICATION 1 0.0019
141 RADIATION INJURY 2 0.0019
142 COLON CANCER METASTATIC 3 0.0019
143 PULMONARY TOXICITY 13 0.0018
144 BRONCHOSTENOSIS 1 0.0018
145 METASTASES TO KIDNEY 1 0.0018
146 CHOLESTATIC LIVER INJURY 4 0.0018
147 CHOLANGITIS 11 0.0018
148 MECHANICAL ILEUS 1 0.0018
149 SERONEGATIVE ARTHRITIS 2 0.0017
150 AUTOIMMUNE HEPATITIS 12 0.0017
151 BILE DUCT CANCER 2 0.0017
152 COLON CANCER STAGE IV 1 0.0017
153 LYMPHATIC DISORDER 1 0.0017
154 CHOLESTASIS 32 0.0017
155 GAMMA-GLUTAMYLTRANSFERASE ABNORMAL 1 0.0017
156 PANCREATIC NEOPLASM 2 0.0016
157 CORTISOL INCREASED 1 0.0016
158 METASTASES TO PERITONEUM 4 0.0016
159 METASTASES TO PELVIS 1 0.0016
160 CANCER PAIN 4 0.0016
161 ENDOCRINE DISORDER 2 0.0016
162 CHORIORETINITIS 1 0.0016
163 RHEUMATIC DISORDER 3 0.0016
164 MAGNETIC RESONANCE IMAGING HEAD ABNORMAL 1 0.0015
165 HYPERMAGNESAEMIA 1 0.0015
166 BONE OPERATION 1 0.0015
167 HOSPICE CARE 15 0.0015
168 LUNG OPACITY 4 0.0015
169 CELL DEATH 3 0.0015
170 ASPARTATE AMINOTRANSFERASE INCREASED 80 0.0015
171 SOFT TISSUE NECROSIS 1 0.0015
172 BRAIN CANCER METASTATIC 1 0.0014
173 NUTRITIONAL CONDITION ABNORMAL 1 0.0014
174 ALANINE AMINOTRANSFERASE ABNORMAL 3 0.0014
175 PRERENAL FAILURE 2 0.0014
176 PELVIC FLUID COLLECTION 1 0.0014
177 NONINFECTIVE ENCEPHALITIS 1 0.0014
178 PERIODONTITIS 3 0.0014
179 GASTROINTESTINAL SCARRING 1 0.0014
180 IMMUNE-MEDIATED ENTEROCOLITIS 5 0.0014
181 RETINAL VASCULAR OCCLUSION 1 0.0013
182 NEURODERMATITIS 5 0.0013
183 MIXED LIVER INJURY 4 0.0013
184 PERFORATED ULCER 1 0.0013
185 ALANINE AMINOTRANSFERASE INCREASED 81 0.0013
186 BLOOD ALKALINE PHOSPHATASE INCREASED 32 0.0013
187 MYCOPLASMA INFECTION 1 0.0013
188 BRONCHIAL CARCINOMA 1 0.0013
189 PNEUMONITIS 34 0.0012
190 ORGANISING PNEUMONIA 6 0.0012
191 ADRENAL MASS 1 0.0012
192 HEPATIC ENZYME ABNORMAL 6 0.0012
193 ENZYME LEVEL INCREASED 1 0.0012
194 OVARIAN CANCER METASTATIC 1 0.0012
195 GAMMA-GLUTAMYLTRANSFERASE INCREASED 26 0.0012
196 PRODUCT USE IN UNAPPROVED THERAPEUTIC ENVIRONMENT 1 0.0011
197 JAUNDICE CHOLESTATIC 4 0.0011
198 INCORRECT PRODUCT FORMULATION ADMINISTERED 1 0.0011
199 LIVER DISORDER 49 0.0011
200 ARTERIOVENOUS MALFORMATION 1 0.0011
201 METASTASES TO ADRENALS 1 0.0011
202 SKIN TOXICITY 6 0.0011
203 INTERVERTEBRAL DISCITIS 2 0.0011
204 HYPOPROTEINAEMIA 2 0.0011
205 NEUTROPENIC INFECTION 1 0.0010
206 CEREBELLAR ATAXIA 1 0.0010
207 BLOOD URINE 1 0.0010
208 METASTASES TO LYMPH NODES 7 0.0010
209 METASTASES TO BONE 17 0.0010
210 HYPOCOAGULABLE STATE 1 0.0010
211 LARGE INTESTINAL STENOSIS 2 0.0010
212 ILEAL ULCER 1 0.0010
213 DRUG-INDUCED LIVER INJURY 31 0.0010
214 EYE COLOUR CHANGE 1 0.0010
215 PRODUCT TEMPERATURE EXCURSION ISSUE 5 0.0010
216 METASTASES TO SKIN 1 0.0010
217 LYMPHANGIOSIS CARCINOMATOSA 1 0.0010
218 METASTASES TO PLEURA 1 0.0010
219 INNER EAR DISORDER 1 0.0009
220 GALLBLADDER ENLARGEMENT 1 0.0009
221 BONE NEOPLASM 1 0.0009
222 BLADDER DILATATION 1 0.0009
223 PARONYCHIA 4 0.0009
224 HYPOCALCAEMIA 17 0.0009
225 TERMINAL STATE 6 0.0009
226 GASTROINTESTINAL ULCER HAEMORRHAGE 1 0.0009
227 CATHETER SITE DISCHARGE 1 0.0009
228 BLOOD BILIRUBIN INCREASED 24 0.0009
229 BENIGN NEOPLASM 1 0.0009
230 COLITIS 33 0.0009
231 FOLATE DEFICIENCY 1 0.0009
232 MACROCYTOSIS 1 0.0009
233 PROCALCITONIN INCREASED 1 0.0009
234 BILE DUCT STENOSIS 1 0.0008
235 EYELID SKIN DRYNESS 1 0.0008
236 CEREBRAL ARTERY EMBOLISM 1 0.0008
237 EJECTION FRACTION ABNORMAL 1 0.0008
238 INTERVERTEBRAL DISC OPERATION 1 0.0008
239 AORTIC VALVE REPLACEMENT 1 0.0008
240 HYPOMAGNESAEMIA 11 0.0008
241 FRACTURED COCCYX 1 0.0008
242 JAUNDICE 21 0.0008
243 ADENOCARCINOMA PANCREAS 1 0.0008
244 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 26 0.0008
245 ACQUIRED GENE MUTATION 1 0.0008
246 GLYCOSURIA 1 0.0007
247 GASTRIC PERFORATION 2 0.0007
248 CARBON DIOXIDE INCREASED 1 0.0007
249 BILIARY TRACT DISORDER 1 0.0007
250 GASTROINTESTINAL PERFORATION 3 0.0007
251 HEPATIC ENZYME INCREASED 49 0.0007
252 LUNG CONSOLIDATION 2 0.0007
253 PROTHROMBIN TIME SHORTENED 1 0.0007
254 CHOLECYSTITIS ACUTE 4 0.0007
255 CONNECTIVE TISSUE DISORDER 1 0.0007
256 INTENSIVE CARE 1 0.0007
257 PANCREATIC CARCINOMA METASTATIC 2 0.0007
258 HEPATIC PAIN 3 0.0007
259 MENINGITIS BACTERIAL 1 0.0007
260 BLADDER TRANSITIONAL CELL CARCINOMA 1 0.0007
261 METASTATIC NEOPLASM 3 0.0007
262 BLOOD MAGNESIUM DECREASED 6 0.0007
263 HEPATIC LESION 3 0.0007
264 METASTASES TO LUNG 8 0.0007
265 HAEMOTHORAX 2 0.0007
266 PULMONARY PAIN 2 0.0007
267 ONYCHOMYCOSIS 3 0.0007
268 METASTASES TO LIVER 12 0.0007
269 NORMOCYTIC ANAEMIA 1 0.0007
270 BLOOD CREATINE INCREASED 3 0.0007
271 PITUITARY TUMOUR 1 0.0007
272 MENINGITIS ASEPTIC 3 0.0007
273 GASTROINTESTINAL WALL THICKENING 1 0.0007
274 HEPATITIS 17 0.0007
275 HEPATITIS CHOLESTATIC 4 0.0007
276 SMALL CELL LUNG CANCER 1 0.0007
277 ORAL MUCOSAL EXFOLIATION 1 0.0007
278 ABDOMINAL HERNIA 3 0.0007
279 INFECTIOUS PLEURAL EFFUSION 1 0.0007
280 DYSCHEZIA 2 0.0007
281 PALLIATIVE CARE 1 0.0007
282 IMMUNE-MEDIATED ADVERSE REACTION 1 0.0007
283 PERFORMANCE STATUS DECREASED 3 0.0006
284 ONYCHOLYSIS 1 0.0006
285 MEGACOLON 1 0.0006
286 COLITIS MICROSCOPIC 3 0.0006
287 INHIBITORY DRUG INTERACTION 1 0.0006
288 TUMOUR MARKER INCREASED 3 0.0006
289 ADVERSE REACTION 8 0.0006
290 INTERSTITIAL LUNG DISEASE 29 0.0006
291 METASTASES TO SPINE 2 0.0006
292 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 2 0.0006
293 HEPATORENAL SYNDROME 1 0.0006
294 CEREBELLAR INFARCTION 1 0.0006
295 FEMORAL NECK FRACTURE 3 0.0006
296 APLASIA PURE RED CELL 2 0.0006
297 BLOOD CREATININE ABNORMAL 2 0.0006
298 SPINAL CORD INJURY 1 0.0006
299 GASTROINTESTINAL OEDEMA 1 0.0006
300 PNEUMOMEDIASTINUM 1 0.0006
301 MONOPARESIS 1 0.0006
302 OESOPHAGITIS 6 0.0005
303 IMMUNE-MEDIATED LUNG DISEASE 1 0.0005
304 ESSENTIAL HYPERTENSION 1 0.0005
305 SINUS NODE DYSFUNCTION 1 0.0005
306 BRAIN NEOPLASM 5 0.0005
307 AMYLASE INCREASED 2 0.0005
308 TRANSAMINASES INCREASED 12 0.0005
309 CARDIAC DYSFUNCTION 2 0.0005
310 COLON CANCER 8 0.0005
311 ADENOCARCINOMA OF COLON 1 0.0005
312 NARCOLEPSY 1 0.0005
313 CHEMOTHERAPY 2 0.0005
314 HAEMATOTOXICITY 5 0.0005
315 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 2 0.0005
316 THYROID MASS 2 0.0005
317 DIARRHOEA 334 0.0005
318 ARTERIAL THROMBOSIS 1 0.0005
319 METABOLIC DISORDER 3 0.0005
320 REHABILITATION THERAPY 2 0.0005
321 HYPOALBUMINAEMIA 4 0.0005
322 IMMUNE-MEDIATED HEPATIC DISORDER 1 0.0005
323 BICYTOPENIA 1 0.0005
324 JOINT NOISE 1 0.0005
325 RESPIRATORY ACIDOSIS 2 0.0005
326 CHOLECYSTITIS 6 0.0005
327 EMPYEMA 1 0.0005
328 RECURRENT CANCER 2 0.0005
329 OSTEOLYSIS 1 0.0005
330 CHOLANGITIS SCLEROSING 1 0.0005
331 HYPERPARATHYROIDISM 1 0.0005
332 NEUTROPENIC COLITIS 1 0.0005
333 PULMONARY ARTERIAL HYPERTENSION 7 0.0005
334 DEATH 415 0.0005
335 HYPOKALAEMIA 22 0.0005
336 PERICARDIAL EFFUSION 11 0.0005
337 AORTIC VALVE INCOMPETENCE 2 0.0005
338 LUNG NEOPLASM 2 0.0005
339 RADIATION PNEUMONITIS 1 0.0005
340 HEPATITIS ACUTE 3 0.0005
341 COLONOSCOPY 1 0.0005
342 CLOSTRIDIUM TEST POSITIVE 1 0.0005
343 ACUTE RESPIRATORY DISTRESS SYNDROME 8 0.0005
344 FAECES PALE 1 0.0004
345 SMALL INTESTINE CARCINOMA 1 0.0004
346 LARGE INTESTINAL OBSTRUCTION 1 0.0004
347 MALNUTRITION 5 0.0004
348 FEAR OF DEATH 1 0.0004
349 GENERAL PHYSICAL CONDITION ABNORMAL 3 0.0004
350 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
351 PNEUMOTHORAX 7 0.0004
352 PERIARTHRITIS 1 0.0004
353 ACUTE HEPATIC FAILURE 6 0.0004
354 DISEASE COMPLICATION 2 0.0004
355 NEOPLASM 5 0.0004
356 EYE OPERATION 2 0.0004
357 HAEMANGIOMA 1 0.0004
358 CARDIAC TAMPONADE 2 0.0004
359 METASTASIS 3 0.0004
360 OXYGEN CONSUMPTION INCREASED 1 0.0004
361 PULSE ABNORMAL 1 0.0004
362 PANNICULITIS 1 0.0004
363 FAECES SOFT 3 0.0004
364 PRODUCT PACKAGING CONFUSION 1 0.0004
365 PLEURAL EFFUSION 25 0.0004
366 DENTAL OPERATION 1 0.0004
367 ILEUS 5 0.0004
368 HEPATIC FAILURE 12 0.0004
369 ABDOMINAL INFECTION 1 0.0004
370 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 4 0.0004
371 AORTIC ARTERIOSCLEROSIS 1 0.0004
372 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
373 HEPATITIS TOXIC 1 0.0004
374 PRODUCT USE COMPLAINT 6 0.0004
375 THERAPEUTIC PRODUCT EFFECT DECREASED 17 0.0004
376 THERAPY NON-RESPONDER 17 0.0004
377 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
378 ASCITES 11 0.0004
379 NEOPLASM PROGRESSION 13 0.0004
380 COMPRESSION FRACTURE 2 0.0004
381 SKIN WRINKLING 1 0.0004
382 LIVER INJURY 9 0.0004
383 CENTRAL NERVOUS SYSTEM LESION 5 0.0004
384 ADVERSE EVENT 33 0.0004
385 PROCTITIS 1 0.0004
386 RENAL TUBULAR DISORDER 1 0.0004
387 ATYPICAL FEMUR FRACTURE 1 0.0004
388 GASTROINTESTINAL DISORDER 31 0.0003
389 DYSPNOEA AT REST 1 0.0003
390 PRODUCT LABEL CONFUSION 2 0.0003
391 PERIPHERAL SENSORY NEUROPATHY 2 0.0003
392 TUMOUR LYSIS SYNDROME 3 0.0003
393 HEPATITIS FULMINANT 1 0.0003
394 HAEMOLYTIC ANAEMIA 3 0.0003
395 ELECTROCARDIOGRAM QT PROLONGED 12 0.0003
396 HYPERCAPNIA 1 0.0003
397 DECREASED APPETITE 77 0.0003
398 TOXIC EPIDERMAL NECROLYSIS 5 0.0003
399 ILL-DEFINED DISORDER 20 0.0003
400 PROSTATITIS 1 0.0003
401 PULMONARY EMBOLISM 31 0.0003
402 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
403 DIASTOLIC DYSFUNCTION 1 0.0003
404 MULTIPLE-DRUG RESISTANCE 1 0.0003
405 ERYTHEMA MULTIFORME 3 0.0003
406 PANCREATIC CARCINOMA STAGE IV 1 0.0003
407 ABDOMINAL ADHESIONS 1 0.0003
408 BILE DUCT STONE 1 0.0003
409 ORTHOPNOEA 1 0.0003
410 LOSS OF THERAPEUTIC RESPONSE 1 0.0003
411 PNEUMONIA VIRAL 1 0.0003
412 ENTERITIS 2 0.0003
413 ACUTE RESPIRATORY FAILURE 6 0.0003
414 CHROMATURIA 7 0.0003
415 LIVER FUNCTION TEST ABNORMAL 9 0.0003
416 LIVER ABSCESS 1 0.0003
417 THERAPY INTERRUPTED 22 0.0003
418 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
419 VITAMIN D DEFICIENCY 3 0.0003
420 FACET JOINT SYNDROME 1 0.0003
421 HEPATIC NEOPLASM 1 0.0003
422 OFF LABEL USE 268 0.0003
423 THERAPY CHANGE 3 0.0003
424 GENERAL PHYSICAL HEALTH DETERIORATION 35 0.0003
425 NEPHRITIS 1 0.0003
426 PROSTATE CANCER METASTATIC 1 0.0003
427 CEREBRAL HAEMATOMA 1 0.0003
428 PRODUCT STORAGE ERROR 26 0.0003
429 NEOPLASM RECURRENCE 1 0.0003
430 HEPATIC CYST 1 0.0003
431 THERAPY CESSATION 15 0.0003
432 UNEVALUABLE EVENT 22 0.0003
433 LEFT VENTRICULAR FAILURE 1 0.0003
434 RESPIRATION ABNORMAL 2 0.0003
435 HYPERBILIRUBINAEMIA 3 0.0003
436 NEUROTOXICITY 5 0.0003
437 ERYTHEMA NODOSUM 1 0.0003
438 PANCREATITIS 15 0.0003
439 NECROTISING FASCIITIS 1 0.0003
440 SUDDEN DEATH 3 0.0003
441 MALIGNANT NEOPLASM PROGRESSION 29 0.0003
442 PRODUCT SUPPLY ISSUE 2 0.0003
443 MONOCYTE COUNT INCREASED 1 0.0003
444 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 8 0.0003
445 ORAL DISORDER 2 0.0003
446 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
447 ARTHROPOD BITE 2 0.0003
448 BONE DENSITY ABNORMAL 1 0.0003
449 TROPONIN INCREASED 2 0.0003
450 HYPERTHERMIA 2 0.0003
451 CLAVICLE FRACTURE 1 0.0003
452 PULMONARY FIBROSIS 5 0.0003
453 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
454 FAECES HARD 1 0.0003
455 HYPERKALAEMIA 9 0.0003
456 EPIGASTRIC DISCOMFORT 1 0.0003
457 COVID-19 PNEUMONIA 3 0.0003
458 PNEUMONIA FUNGAL 1 0.0003
459 BLOOD ALBUMIN DECREASED 2 0.0003
460 RENAL CYST 2 0.0003
461 HAEMOPTYSIS 7 0.0003
462 TRANSPLANT REJECTION 2 0.0002
463 BLOOD DISORDER 2 0.0002
464 INTRACRANIAL ANEURYSM 1 0.0002
465 RHINITIS 2 0.0002
466 CEREBRAL INFARCTION 6 0.0002
467 ADVERSE DRUG REACTION 22 0.0002
468 HYPERURICAEMIA 1 0.0002
469 LEG AMPUTATION 1 0.0002
470 EMBOLISM 2 0.0002
471 NEOPLASM MALIGNANT 16 0.0002
472 ONYCHOMADESIS 1 0.0002
473 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
474 CARDIAC FAILURE CHRONIC 1 0.0002
475 DRUG RESISTANCE 6 0.0002
476 PYELONEPHRITIS 2 0.0002
477 ATRIOVENTRICULAR BLOCK FIRST DEGREE 1 0.0002
478 BONE CANCER 1 0.0002
479 DIVERTICULUM INTESTINAL 1 0.0002
480 HOSPITALISATION 35 0.0002
481 RHINITIS ALLERGIC 1 0.0002
482 IRON DEFICIENCY 1 0.0002
483 SUSPECTED OFF LABEL USE 1 0.0002
484 OPTIC NEURITIS 2 0.0002
485 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
486 HYPOTHYROIDISM 7 0.0002
487 EAR DISORDER 1 0.0002
488 ARTHRITIS INFECTIVE 1 0.0002
489 RENAL FUNCTION TEST ABNORMAL 1 0.0002
490 APHONIA 3 0.0002
491 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 5 0.0002
492 FEELING OF DESPAIR 1 0.0002
493 SKIN REACTION 3 0.0002
494 SQUAMOUS CELL CARCINOMA 2 0.0002
495 PROTEINURIA 4 0.0002
496 NEUROPATHY PERIPHERAL 20 0.0002
497 MUSCULOSKELETAL DISORDER 4 0.0002
498 SKIN DISORDER 7 0.0002
499 INCREASED APPETITE 4 0.0002
500 LIMB OPERATION 1 0.0002
501 SEPTIC SHOCK 9 0.0002
502 RASH VESICULAR 1 0.0002
503 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
504 INCORRECT DOSAGE ADMINISTERED 1 0.0002
505 RENAL IMPAIRMENT 17 0.0002
506 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
507 PULMONARY MASS 3 0.0002
508 ANEURYSM 1 0.0002
509 PNEUMONIA 65 0.0002
510 PNEUMONIA ASPIRATION 5 0.0002
511 PRODUCT ADMINISTRATION ERROR 4 0.0002
512 DYSPHORIA 1 0.0002
513 FEEDING DISORDER 4 0.0002
514 PATHOLOGICAL FRACTURE 1 0.0002
515 DRUG INTOLERANCE 19 0.0002
516 HYPOPHAGIA 5 0.0002
517 DEHYDRATION 26 0.0002
518 CACHEXIA 1 0.0002
519 CEREBRAL ISCHAEMIA 1 0.0002
520 FAILURE TO THRIVE 1 0.0002
521 RESPIRATORY FAILURE 14 0.0002
522 ANAEMIA 36 0.0002
523 BONE PAIN 11 0.0002
524 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
525 INTESTINAL OBSTRUCTION 7 0.0002
526 HIP SURGERY 1 0.0002
527 OEDEMA 10 0.0002
528 HYDROCEPHALUS 1 0.0002
529 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 13 0.0002
530 NONSPECIFIC REACTION 1 0.0002
531 DRUG LEVEL BELOW THERAPEUTIC 1 0.0002
532 RESPIRATORY DISTRESS 5 0.0002
533 GASTRIC ULCER HAEMORRHAGE 1 0.0002
534 ANGIOPATHY 1 0.0002
535 ACUTE PULMONARY OEDEMA 1 0.0002
536 NEPHROPATHY TOXIC 2 0.0002
537 MYOCARDIAL ISCHAEMIA 2 0.0002
538 RED BLOOD CELL COUNT DECREASED 5 0.0002
539 BLOOD CREATINE PHOSPHOKINASE INCREASED 5 0.0002
540 HERPES VIRUS INFECTION 1 0.0002
541 ENTEROCOLITIS 1 0.0002
542 HYPERVENTILATION 1 0.0002
543 ELECTROLYTE IMBALANCE 2 0.0002
544 MUSCULOSKELETAL PAIN 9 0.0002
545 HYPOVOLAEMIA 1 0.0002
546 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
547 THROMBOCYTOPENIA 19 0.0002
548 CONSTIPATION 37 0.0002
549 ENERGY INCREASED 1 0.0002
550 COLORECTAL CANCER 8 0.0002
551 CARDIO-RESPIRATORY ARREST 7 0.0002
552 HYPERLIPIDAEMIA 2 0.0002
553 BLOOD POTASSIUM DECREASED 5 0.0002
554 BLOOD PRESSURE INADEQUATELY CONTROLLED 1 0.0002
555 CONTRAINDICATED PRODUCT ADMINISTERED 5 0.0002
556 ADRENAL INSUFFICIENCY 2 0.0002
557 BONE DISORDER 3 0.0002
558 INGUINAL HERNIA 1 0.0002
559 LUNG DISORDER 8 0.0002
560 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
561 SMALL INTESTINAL OBSTRUCTION 2 0.0002
562 TUBULOINTERSTITIAL NEPHRITIS 3 0.0002
563 HYPONATRAEMIA 9 0.0002
564 BLOOD SODIUM DECREASED 3 0.0002
565 BRAIN OEDEMA 2 0.0002
566 PHOTOPSIA 1 0.0002
567 FOREIGN BODY SENSATION IN EYES 1 0.0002
568 C-REACTIVE PROTEIN ABNORMAL 1 0.0002
569 HERNIA 3 0.0002
570 HIATUS HERNIA 2 0.0002
571 SKIN FISSURES 3 0.0002
572 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 8 0.0002
573 MYALGIA 26 0.0002
574 FATIGUE 119 0.0002
575 ASPERGILLUS INFECTION 1 0.0002
576 GASTRITIS 4 0.0002
577 INFECTION 22 0.0002
578 ASTHENIA 57 0.0002
579 BLOOD PRESSURE ABNORMAL 3 0.0002
580 APPETITE DISORDER 1 0.0002
581 NAUSEA 119 0.0002
582 PLATELET COUNT DECREASED 16 0.0001
583 BREAST MASS 1 0.0001
584 COLITIS ISCHAEMIC 1 0.0001
585 POSTOPERATIVE WOUND INFECTION 1 0.0001
586 ILLNESS 15 0.0001
587 ONYCHOCLASIS 1 0.0001
588 EXTRASYSTOLES 1 0.0001
589 HEPATOCELLULAR INJURY 2 0.0001
590 SINUS TACHYCARDIA 2 0.0001
591 DIVERTICULUM 1 0.0001
592 NEUTROPENIC SEPSIS 1 0.0001
593 CEREBRAL HAEMORRHAGE 5 0.0001
594 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
595 DERMATITIS BULLOUS 1 0.0001
596 BLOOD CREATININE INCREASED 9 0.0001
597 RASH PUSTULAR 1 0.0001
598 ABDOMINAL DISCOMFORT 23 0.0001
599 CARDIAC FAILURE 11 0.0001
600 BLINDNESS TRANSIENT 1 0.0001
601 CARDIOMYOPATHY 2 0.0001
602 CEREBRAL DISORDER 1 0.0001
603 IMMUNODEFICIENCY 2 0.0001
604 RESPIRATORY DISORDER 4 0.0001
605 HYDRONEPHROSIS 1 0.0001
606 DRUG INTERACTION 21 0.0001
607 COUGH 37 0.0001
608 EPILEPSY 4 0.0001
609 ACIDOSIS 1 0.0001
610 LIPASE INCREASED 1 0.0001
611 INTERCEPTED PRODUCT ADMINISTRATION ERROR 1 0.0001
612 PROCEDURAL COMPLICATION 1 0.0001
613 DIFFUSE LARGE B-CELL LYMPHOMA 1 0.0001
614 ATRIOVENTRICULAR BLOCK 1 0.0001
615 MUSCULOSKELETAL CHEST PAIN 2 0.0001
616 GASTROINTESTINAL INFLAMMATION 1 0.0001
617 NEUTROPENIA 17 0.0001
618 ACUTE KIDNEY INJURY 19 0.0001
619 STENT PLACEMENT 1 0.0001
620 MYASTHENIA GRAVIS 1 0.0001
621 MUSCULAR WEAKNESS 14 0.0001
622 POST PROCEDURAL INFECTION 1 0.0001
623 SHOCK HAEMORRHAGIC 1 0.0001
624 ESCHERICHIA INFECTION 1 0.0001
625 SPINAL COMPRESSION FRACTURE 1 0.0001
626 CYTOMEGALOVIRUS INFECTION 2 0.0001
627 SECOND PRIMARY MALIGNANCY 1 0.0001
628 HEMIPLEGIA 1 0.0001
629 EOSINOPHIL COUNT INCREASED 1 0.0001
630 RASH 52 0.0001
631 PERICARDITIS 2 0.0001
632 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
633 CHRONIC KIDNEY DISEASE 9 0.0001
634 DIABETES MELLITUS 9 0.0001
635 OEDEMA PERIPHERAL 14 0.0001
636 VOMITING 54 0.0001
637 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
638 MUCOSAL INFLAMMATION 3 0.0001
639 BLOOD CALCIUM INCREASED 1 0.0001
640 GROIN PAIN 1 0.0001
641 HYPOXIA 4 0.0001
642 IMMUNOSUPPRESSION 1 0.0001
643 CARDIOTOXICITY 1 0.0001
644 ISCHAEMIC STROKE 2 0.0001
645 FACIAL PAIN 1 0.0001
646 THROMBOSIS 9 0.0001
647 DYSPEPSIA 11 0.0001
648 GASTROINTESTINAL INFECTION 1 0.0001
649 GOUT 2 0.0001
650 MYOSITIS 1 0.0001
651 DISTURBANCE IN ATTENTION 6 0.0001
652 ANAL INCONTINENCE 1 0.0001
653 FREQUENT BOWEL MOVEMENTS 3 0.0001
654 LEUKOCYTOSIS 2 0.0001
655 GASTROINTESTINAL CARCINOMA 1 0.0001
656 LIP DRY 1 0.0001
657 EXOSTOSIS 1 0.0001
658 SOMNOLENCE 22 0.0001
659 PNEUMONIA BACTERIAL 1 0.0001
660 PERSONALITY CHANGE 1 0.0001
661 AGRANULOCYTOSIS 2 0.0001
662 HEPATIC ENCEPHALOPATHY 1 0.0001
663 ARTERIOSCLEROSIS 1 0.0001
664 FRACTURE 2 0.0001
665 SPINAL DISORDER 1 0.0001
666 ACNE 8 0.0001
667 DYSPHAGIA 10 0.0001
668 GASTRIC ULCER 2 0.0001
669 DRY SKIN 14 0.0001
670 HYPERSOMNIA 3 0.0001
671 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
672 HYPERCHOLESTEROLAEMIA 1 0.0001
673 ERUCTATION 2 0.0001
674 AUTOIMMUNE DISORDER 1 0.0001
675 CHOKING 2 0.0001
676 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
677 HEPATOMEGALY 1 0.0001
678 PYREXIA 35 0.0001
679 BLADDER DISORDER 1 0.0001
680 INABILITY TO AFFORD MEDICATION 1 0.0001
681 CEREBROVASCULAR ACCIDENT 17 0.0001
682 PRESCRIBED UNDERDOSE 2 0.0001
683 BRAIN INJURY 1 0.0001
684 GASTROOESOPHAGEAL REFLUX DISEASE 8 0.0001
685 EMPHYSEMA 1 0.0001
686 ABDOMINAL PAIN 23 0.0001
687 EYELID PTOSIS 1 0.0001
688 DRY THROAT 1 0.0001
689 DYSPNOEA 55 0.0001
690 CARDIAC ARREST 8 0.0001
691 DERMATITIS 2 0.0001
692 FOLLICULITIS 1 0.0001
693 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
694 HIP FRACTURE 3 0.0001
695 PHARYNGITIS STREPTOCOCCAL 1 0.0001
696 MENTAL DISORDER 4 0.0001
697 PRODUCT DISPENSING ERROR 2 0.0001
698 PULMONARY THROMBOSIS 1 0.0001
699 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
700 ASPIRATION 1 0.0001
701 MELAENA 2 0.0001
702 FOOT DEFORMITY 1 0.0001
703 NERVE INJURY 1 0.0001
704 HYPERTENSIVE CRISIS 1 0.0001
705 HYPERTENSION 19 0.0001
706 PULMONARY OEDEMA 4 0.0001
707 RASH PAPULAR 2 0.0001
708 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
709 PANCREATITIS ACUTE 2 0.0001
710 OXYGEN SATURATION DECREASED 5 0.0001
711 FISTULA 1 0.0001
712 REBOUND EFFECT 1 0.0001
713 IMPAIRED DRIVING ABILITY 1 0.0001
714 CHEST DISCOMFORT 9 0.0001
715 SCAB 1 0.0001
716 INTERNAL HAEMORRHAGE 1 0.0001
717 MYOCARDITIS 1 0.0001
718 SKIN DISCOLOURATION 4 0.0001
719 HERPES ZOSTER 5 0.0001
720 POST PROCEDURAL HAEMORRHAGE 1 0.0001
721 RENAL DISORDER 4 0.0001
722 CARDIAC DISORDER 8 0.0001
723 SURGERY 5 0.0001
724 LYMPHADENOPATHY 3 0.0001
725 TREATMENT FAILURE 7 0.0001
726 CATARACT 5 0.0001
727 PRODUCTIVE COUGH 4 0.0001
728 POLYNEUROPATHY 1 0.0001
729 BLOOD PRESSURE FLUCTUATION 2 0.0001
730 PRURITUS 32 0.0001
731 RENAL FAILURE 11 0.0001
732 HYPOGLYCAEMIA 4 0.0001
733 CYTOPENIA 1 0.0001
734 CARDIOMEGALY 1 0.0001
735 GENERALISED OEDEMA 1 0.0001
736 PEMPHIGUS 1 0.0001
737 INTENTIONAL PRODUCT MISUSE 7 0.0001
738 CELLULITIS 4 0.0001
739 WEIGHT DECREASED 22 0.0001
740 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
741 SEIZURE 9 0.0001
742 HAEMOGLOBIN DECREASED 8 0.0001
743 ROTATOR CUFF SYNDROME 1 0.0001
744 PLATELET COUNT INCREASED 1 0.0001
745 ABDOMINAL DISTENSION 8 0.0001
746 NERVOUSNESS 4 0.0001
747 DEAFNESS 2 0.0001
748 IMMUNE SYSTEM DISORDER 1 0.0001
749 MALAISE 33 0.0001
750 BREAST CANCER FEMALE 2 0.0001
751 JOINT RANGE OF MOTION DECREASED 1 0.0001
752 COVID-19 13 0.0001
753 SINUS CONGESTION 1 0.0001
754 NEUTROPHIL COUNT DECREASED 3 0.0001
755 IMPAIRED GASTRIC EMPTYING 1 0.0001
756 BACK PAIN 17 0.0001
757 TREATMENT NONCOMPLIANCE 4 0.0001
758 SKIN LESION 2 0.0001
759 PERIPHERAL COLDNESS 1 0.0001
760 ABNORMAL DREAMS 2 0.0001
761 ORAL DISCOMFORT 1 0.0001
762 SEPSIS 8 0.0001
763 COORDINATION ABNORMAL 1 0.0001
764 DEMENTIA 2 0.0001
765 WOUND 2 0.0001
766 BLOOD TEST ABNORMAL 1 0.0001
767 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
768 LYMPHOPENIA 1 0.0001
769 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
770 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
771 FLATULENCE 4 0.0001
772 URINARY TRACT INFECTION 12 0.0001
773 INTENTIONAL DOSE OMISSION 2 0.0001
774 INCORRECT DOSE ADMINISTERED 16 0.0001
775 SUBDURAL HAEMATOMA 1 0.0001
776 ANGINA PECTORIS 2 0.0001
777 CARDIOGENIC SHOCK 1 0.0001
778 HYPERTHYROIDISM 1 0.0001
779 PAIN 42 0.0001
780 LABORATORY TEST ABNORMAL 2 0.0001
781 OESOPHAGEAL CARCINOMA 2 0.0001
782 HAEMORRHAGE INTRACRANIAL 1 0.0001
783 HYPOAESTHESIA 10 0.0001
784 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
785 STOMATITIS 4 0.0001
786 OSTEOPENIA 1 0.0001
787 MEMORY IMPAIRMENT 9 0.0001
788 INSURANCE ISSUE 1 0.0001
789 HIP ARTHROPLASTY 1 0.0001
790 DEVICE RELATED INFECTION 1 0.0001
791 ARTHRALGIA 27 0.0001
792 PERIPHERAL SWELLING 10 0.0001
793 LYMPHOMA 1 0.0001
794 LIMB DISCOMFORT 2 0.0001
795 PAIN IN EXTREMITY 19 0.0001
796 COGNITIVE DISORDER 3 0.0001
797 ACUTE MYELOID LEUKAEMIA 1 0.0001
798 NERVOUS SYSTEM DISORDER 2 0.0001
799 BRAIN FOG 1 0.0001
800 ARTHRITIS 5 0.0001
801 ARRHYTHMIA 3 0.0001
802 FALL 21 0.0001
803 OBESITY 1 0.0001
804 BLOOD GLUCOSE DECREASED 3 0.0001
805 CARDIAC FAILURE CONGESTIVE 5 0.0001
806 BLOOD POTASSIUM INCREASED 1 0.0001
807 CHOLELITHIASIS 2 0.0001
808 MULTIPLE FRACTURES 1 0.0001
809 EYE DISORDER 2 0.0001
810 FEBRILE NEUTROPENIA 4 0.0001
811 BLOOD PRESSURE DECREASED 4 0.0001
812 VIRAL INFECTION 2 0.0001
813 GAIT INABILITY 2 0.0001
814 BLOOD UREA INCREASED 1 0.0001
815 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
816 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
817 BALANCE DISORDER 5 0.0001
818 DELIRIUM 2 0.0001
819 ORTHOSTATIC HYPOTENSION 1 0.0001
820 DRUG INEFFECTIVE 75 0.0001
821 COLD SWEAT 1 0.0001
822 DRUG ERUPTION 1 0.0001
823 TACHYCARDIA 5 0.0001
824 GALLBLADDER DISORDER 1 0.0001
825 MYELOSUPPRESSION 2 0.0001
826 GASTROENTERITIS VIRAL 1 0.0001
827 RASH PRURITIC 3 0.0001
828 OSTEOMYELITIS 1 0.0001
829 HYPERGLYCAEMIA 2 0.0001
830 BLOOD GLUCOSE ABNORMAL 1 0.0001
831 BRONCHITIS 4 0.0001
832 CONJUNCTIVITIS 1 0.0001
833 PANCYTOPENIA 3 0.0001
834 BACTERIAL INFECTION 1 0.0001
835 DYSPNOEA EXERTIONAL 2 0.0001
836 BLOOD URINE PRESENT 1 0.0001
837 POST PROCEDURAL COMPLICATION 1 0.0001
838 ATRIAL FIBRILLATION 5 0.0001
839 DYSPHONIA 3 0.0001
840 HAEMORRHOIDS 1 0.0001
841 CHILLS 6 0.0001
842 KIDNEY INFECTION 1 0.0001
843 BLADDER CANCER 3 0.0001
844 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
845 SINUS DISORDER 1 0.0001
846 HAEMATOCRIT DECREASED 1 0.0001
847 CYTOKINE RELEASE SYNDROME 1 0.0000
848 PRODUCT PHYSICAL ISSUE 1 0.0000
849 THERAPEUTIC RESPONSE DECREASED 3 0.0000
850 CONDITION AGGRAVATED 15 0.0000
851 TASTE DISORDER 1 0.0000
852 BONE MARROW FAILURE 1 0.0000
853 MUSCLE SPASMS 9 0.0000
854 RIB FRACTURE 1 0.0000
855 PERITONITIS 1 0.0000
856 RHABDOMYOLYSIS 2 0.0000
857 PRODUCT DOSE OMISSION ISSUE 14 0.0000
858 MOUTH ULCERATION 1 0.0000
859 RECTAL HAEMORRHAGE 2 0.0000
860 RHINORRHOEA 3 0.0000
861 DEEP VEIN THROMBOSIS 3 0.0000
862 FAECES DISCOLOURED 1 0.0000
863 PRODUCT PRESCRIBING ISSUE 1 0.0000
864 ALOPECIA 9 0.0000
865 MUSCULOSKELETAL STIFFNESS 4 0.0000
866 COLITIS ULCERATIVE 2 0.0000
867 HEART RATE IRREGULAR 1 0.0000
868 DEPRESSION 10 0.0000
869 ABDOMINAL PAIN UPPER 9 0.0000
870 SKIN IRRITATION 2 0.0000
871 TREMOR 7 0.0000
872 DIABETIC KETOACIDOSIS 1 0.0000
873 TOXICITY TO VARIOUS AGENTS 7 0.0000
874 PRESYNCOPE 1 0.0000
875 NEURALGIA 1 0.0000
876 ENCEPHALOPATHY 1 0.0000
877 OSTEONECROSIS OF JAW 1 0.0000
878 MYOCARDIAL INFARCTION 7 0.0000
879 EPISTAXIS 3 0.0000
880 AGEUSIA 1 0.0000
881 DRY EYE 2 0.0000
882 GASTRIC CANCER 1 0.0000
883 CARDIOVASCULAR DISORDER 1 0.0000
884 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
885 INFLAMMATION 2 0.0000
886 SKIN ULCER 1 0.0000
887 SPEECH DISORDER 2 0.0000
888 JOINT STIFFNESS 1 0.0000
889 CHEST PAIN 7 0.0000
890 EAR INFECTION 1 0.0000
891 DRY MOUTH 3 0.0000
892 LIMB INJURY 1 0.0000
893 PALLOR 1 0.0000
894 MOOD ALTERED 1 0.0000
895 HAEMATOCHEZIA 2 0.0000
896 PROCEDURAL PAIN 1 0.0000
897 MENTAL STATUS CHANGES 1 0.0000
898 ARTHROPATHY 2 0.0000
899 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
900 NECK PAIN 2 0.0000
901 SKIN EXFOLIATION 3 0.0000
902 ANXIETY 10 0.0000
903 LETHARGY 2 0.0000
904 PANCREATIC CARCINOMA 1 0.0000
905 DYSSTASIA 1 0.0000
906 PALPITATIONS 4 0.0000
907 NASAL CONGESTION 2 0.0000
908 PSYCHOTIC DISORDER 1 0.0000
909 INSOMNIA 9 0.0000
910 WHEEZING 2 0.0000
911 APHASIA 1 0.0000
912 CORONARY ARTERY DISEASE 1 0.0000
913 GYNAECOMASTIA 1 0.0000
914 DIZZINESS 16 0.0000
915 SWELLING 3 0.0000
916 HEADACHE 20 0.0000
917 CYSTITIS 1 0.0000
918 MOOD SWINGS 1 0.0000
919 WEIGHT INCREASED 7 0.0000
920 MOVEMENT DISORDER 1 0.0000
921 NIGHT SWEATS 1 0.0000
922 OSTEONECROSIS 1 0.0000
923 STAPHYLOCOCCAL INFECTION 1 0.0000
924 HEART RATE INCREASED 3 0.0000
925 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
926 EXPIRED PRODUCT ADMINISTERED 1 0.0000
927 FEELING ABNORMAL 7 0.0000
928 HAEMATURIA 1 0.0000
929 HAEMORRHAGE 3 0.0000
930 RASH MACULAR 1 0.0000
931 HEART RATE DECREASED 1 0.0000
932 INJURY 2 0.0000
933 SKIN BURNING SENSATION 2 0.0000
934 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
935 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
936 C-REACTIVE PROTEIN INCREASED 1 0.0000
937 RESTLESSNESS 1 0.0000
938 DYSURIA 1 0.0000
939 BLOOD PRESSURE INCREASED 4 0.0000
940 GAIT DISTURBANCE 5 0.0000
941 PARAESTHESIA 4 0.0000
942 DISORIENTATION 1 0.0000
943 HYPOTENSION 5 0.0000
944 JOINT SWELLING 3 0.0000
945 CONFUSIONAL STATE 4 0.0000
946 EXTRA DOSE ADMINISTERED 1 0.0000
947 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5 0.0000
948 BLINDNESS 1 0.0000
949 ROAD TRAFFIC ACCIDENT 1 0.0000
950 HYPOACUSIS 1 0.0000
951 ANGIOEDEMA 1 0.0000
952 VISION BLURRED 3 0.0000
953 HYPERSENSITIVITY 4 0.0000
954 COMA 1 0.0000
955 RASH ERYTHEMATOUS 1 0.0000
956 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
957 PRODUCT USE IN UNAPPROVED INDICATION 5 0.0000
958 LEUKOPENIA 1 0.0000
959 SYNCOPE 2 0.0000
960 FLUID RETENTION 1 0.0000
961 ERYTHEMA 4 0.0000
962 ECZEMA 1 0.0000
963 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
964 BLISTER 1 0.0000
965 ASTHMA 2 0.0000
966 RHEUMATOID ARTHRITIS 2 0.0000
967 FEELING HOT 1 0.0000
968 NASOPHARYNGITIS 3 0.0000
969 VISUAL IMPAIRMENT 2 0.0000
970 LOSS OF CONSCIOUSNESS 2 0.0000
971 HYPERHIDROSIS 2 0.0000
972 AMNESIA 1 0.0000
973 SWELLING FACE 1 0.0000
974 INFUSION RELATED REACTION 1 0.0000
975 SLEEP DISORDER 1 0.0000
976 MOBILITY DECREASED 1 0.0000
977 DYSGEUSIA 1 0.0000
978 HALLUCINATION 1 0.0000
979 HOT FLUSH 1 0.0000
980 DRUG DOSE OMISSION BY DEVICE 1 0.0000
981 INFLUENZA LIKE ILLNESS 1 0.0000
982 URTICARIA 2 0.0000
983 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
984 OROPHARYNGEAL PAIN 1 0.0000
985 BREAST CANCER 1 0.0000
986 PRODUCT USE ISSUE 2 0.0000
987 SINUSITIS 1 0.0000
988 EMOTIONAL DISTRESS 1 0.0000
989 NO ADVERSE EVENT 1 0.0000
990 BLOOD GLUCOSE INCREASED 1 0.0000